CBP Renames Pharma CEE as "Industry Integration Center for Pharma"
U.S. Customs and Border Protection posted to its website on December 7, 2011, a notice indicating that it has renamed its Center for Excellence and Expertise (CEE) for Pharmaceuticals as the "Industry Integration Center for Pharmaceuticals," and states that it is a central point of contact for inquiries and resolution of issues regarding pharmaceutical imports.
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
CBP states that the trade will be able to contact the Pharmaceuticals Center for assistance in the following areas.
- Technical guidance regarding pharmaceutical imports
- Clarification of CBP policies and procedures for pharmaceutical imports
- Assistance with CBP requests for information/action (CF-28s, CF-29s, etc.)
- Assistance with lengthy cargo holds on pharmaceutical shipments
- Information regarding counterfeit/substandard pharmaceutical imports